New medicines for neurological disease.
Pace Pharmaceuticals is a new kind of drug company. We deeply integrate AI and robotics at all stages, enabling us to develop drugs with unprecedented efficiency.
Explore our compounds →Generate
AI generates and scores analogs around a promising scaffold.
Design
AI designs the assay to test the top candidates.
Test
AI programs liquid-handling robots to run the plates, around the clock.
Analyze
AI analyzes the data and flags the hits.
Iterate
The process is repeated for many different scaffolds.
PAC-832
A selective small-molecule GalR1 antagonist for Alzheimer’s disease.
GalR1–3 concentration response
Novel object discrimination · N = 25
Behavioral recordings
Novel object
Familiar object
Novel object
Familiar object
PAC-3310
A selective small-molecule M4 agonist for schizophrenia.
M1–M5 concentration response
MK-801 hyperlocomotion · n = 11–12/group